Nanoparticles have once again reached the spotlight, this time as a critical tool to combat the spread of covid-19. In this ...

In this Thought Leader article., Ian Johnston from Cytiva discusses challenges related to process development, scaling technology, regulatory approvals, and GMP guidelines.

The in vivo cell therapy seed Carisma Therapeutics planted with Moderna in 2022 is starting to sprout. | The in vivo cell ...

Analysis time of SR-DLS is considerably shorter compared to conventional DLS. A SR-DLS measurement takes less than 10 seconds ...

Third, current methods to deliver the gRNA-ADAR complex use lipid nanoparticles. Researchers used them to great success to ...

A new study shows that a biomedical tool can successfully deliver genetic material to edit faulty genes in developing fetal ...

By filling in the missing link between lipid chemistry and immune response, Carnegie Mellon professor Kathryn Whitehead is helping to expand the use of lipid nanoparticles beyond RNA vaccines.

Prenatal gene therapy via mRNA LNPs fixes faulty genes in fetal brain cells in animal model of neurodevelopmental syndrome.

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / November 4, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global ...

Non-human primate data presented at ESGCT demonstrated selective in vivo delivery of mRNA with T cell-targeted lipid nanoparticle (ctLNP)Cash ...

Researchers have developed a novel delivery system for sending CRISPR reagents to brain cells, where it performs its gene ...